ESR1 and neoplasm: In a recent systematic review and meta-analysis, the conversion rate for estrogen-receptor alpha (ERα) from positive in the primary tumor to negative in the metastasis was 22.5% (95% confidence interval; 16.4 to 30.0%) [6].